Drug Ezetimibe Clinical Trials Updates During the Last 45 Dayshttp://www.clinicaltrialsfeeds.org/clinical-trials/results/term=Drug+EzetimibeClinical trials database search returned results for the query Drug Ezetimibe AND ( "12/31/2011" : MAX ) [LAST-RELEASE-DATE].Tue, 14 Feb 2012 10:22:23 GMTA Study to Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/40 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 40 mg Tablets in Participants With High Cholesterol (MK-0653C-190 AM1)http://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT01370603http://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT01370603Status: Active, not recruiting, Condition Summary: HypercholesterolemiaMon, 23 Jan 2012 05:00:00 GMTA Study to Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/20 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 20 mg Tablets in Participants With High Cholesterol (MK-0653C-185 AM1)http://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT01370590http://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT01370590Status: Active, not recruiting, Condition Summary: HypercholesterolemiaWed, 25 Jan 2012 05:00:00 GMTVytorin in the Treatment of Alopecia Areatahttp://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT01520077http://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT01520077Status: Recruiting, Condition Summary: Alopecia AreataThu, 26 Jan 2012 05:00:00 GMTA Study to Determine the Bioequivalence of SCH 900068 Compared to Marketed Products (Protocol No. P07551)http://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT01236430http://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT01236430Status: Completed, Condition Summary: HyperlipidemiaMon, 16 Jan 2012 05:00:00 GMTStudy of Heart and Renal Protectionhttp://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT00125593http://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT00125593Status: Completed, Condition Summary: Kidney Disease, ChronicTue, 31 Jan 2012 05:00:00 GMTStudy to Assess the Tolerability and Efficacy of AMG-145 in Patients With Hypercholesterolemia Unable to Tolerate an Effective Dose of a Statin.http://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT01375764http://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT01375764Status: Recruiting, Condition Summary: HyperlipidemiaTue, 10 Jan 2012 05:00:00 GMTComprehensive Magnetic Resonance of Peripheral Arterial Diseasehttp://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT00587678http://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT00587678Status: Completed, Condition Summary: Peripheral Artery DiseaseTue, 03 Jan 2012 05:00:00 GMTEfficacy and Safety of Extended Release (ER) Niacin/Laropiprant When Added to Ongoing Lipid-Modifying Therapy in Patients With High Cholesterol or Abnormal Lipid Levels (Protocol MK-0524A-133)http://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT01274559http://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT01274559Status: Recruiting, Condition Summary: Primary Hypercholesterolemia; Mixed DyslipidemiaMon, 30 Jan 2012 05:00:00 GMTEfficiency of Rosuvastatin Versus the Fixed Combination of Ezetimibe/Simvastatin in Outpatientshttp://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT01164397http://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT01164397Status: Completed, Condition Summary: DyslipidemiaTue, 17 Jan 2012 05:00:00 GMTStudy to Assess the Tolerability and Efficacy of AMG-145 Monotherapy in Patients With Hypercholesterolemiahttp://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT01375777http://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT01375777Status: Active, not recruiting, Condition Summary: HyperlipidemiaWed, 18 Jan 2012 05:00:00 GMT